Cleaved IL-1β (Asp117) Antibody (Rabbit mAb) [F15J4]

CatNo: F0836

    Application: Reactivity:
    • Lane 1: Mouse bone marrow derived macrophages, Lane 2: Mouse bone marrow derived macrophages (LPS, 50 ng/ml, 4 h; nigericin, 15 μM, 45 min)
    1/
    サイズ (液体) 価格(税別) 在庫状況
    JPY 19400 国内在庫なし(納期7~10日)
    JPY 42400 国内在庫なし(納期7~10日)
    JPY 63700 お問い合わせ

    代表番号: 045-509-1970|電子メール:sales@selleck.co.jp
    よく尋ねられる質問

    キーポイント

    WB
    転写条件(ウェット): 200 mA, 60 min

    使用情報

    Dilution
    1:1000
    1:50
    Application
    WB, IP
    Source
    Rabbit Monoclonal Antibody
    Reactivity
    Mouse
    Storage Buffer
    PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN3
    Storage (from the date of receipt)
    -20°C (avoid freeze-thaw cycles), 2 years
    Predicted MW
    31 kDa
    ポジティブコントロール mBMDM cells (LPS, 50 ng/ml, 4 h; nigericin, 15 μM, 45 min)
    ネガティブコントロール mBMDM cells

    プロトコール

    WB
    Experimental Protocol:
     
    Sample preparation
    1. Tissue: Lyse the tissue sample by adding an appropriate volume of ice-cold RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail),and homogenize the tissue at a low temperature or lyse it by sonication on ice, then incubate on ice for 30 minutes.
    2. Adherent cell: Aspirate the culture medium and wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail) , sonicate to lyse the cells, and incubate on ice for 30 minutes.
    3. Suspension cell: Transfer the culture medium to a pre-cooled centrifuge tube. Centrifuge and aspirate the supernatant. Wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail) , sonicate to lyse the cells, and incubate on ice for 30 minutes.
    4. Place the lysate into a pre-cooled microcentrifuge tube. Centrifuge at 4°C for 15 min. Collect the supernatant;
    5. Remove a small volume of lysate to determine the protein concentration;
    6. Combine the lysate with protein loading buffer. Boil 20 µL sample under 95-100°C for 5 min. Centrifuge for 5 min after cool down on ice.
     
    Electrophoretic separation
    1. According to the concentration of extracted protein, load appropriate amount of protein sample and marker onto SDS-PAGE gels for electrophoresis. Recommended separating gel (lower gel) concentration: 10%. Reference Table for Selecting SDS-PAGE Separation Gel Concentrations
    2. Power up 80V for 30 minutes. Then the power supply is adjusted (110 V~150 V), the Marker is observed, and the electrophoresis can be stopped when the indicator band of the predyed protein Marker where the protein is located is properly separated. (Note that the current should not be too large when electrophoresis, too large current (more than 150 mA) will cause the temperature to rise, affecting the result of running glue. If high currents cannot be avoided, an ice bath can be used to cool the bath.)
     
    Transfer membrane
    1. Take out the converter, soak the clip and consumables in the pre-cooled converter;
    2. Activate PVDF membrane with methanol for 1 min and rinse with transfer buffer;
    3. Install it in the order of "black edge of clip - sponge - filter paper - filter paper - glue -PVDF membrane - filter paper - filter paper - sponge - white edge of clip";
    4. The protein was electrotransferred to PVDF membrane. ( 0.45 µm PVDF membrane is recommended ) Reference Table for Selecting PVDF Membrane Pore Size Specifications
    Recommended conditions for wet transfer: 200 mA, 60 min.
    ( Note that the transfer conditions can be adjusted according to the protein size. For high-molecular-weight proteins, a higher current and longer transfer time are recommended. However, ensure that the transfer tank remains at a low temperature to prevent gel melting.)
     
    Block
    1. After electrotransfer, wash the film with TBST at room temperature for 5 minutes;
    2. Incubate the film in the blocking solution for 1 hour at room temperature;
    3. Wash the film with TBST for 3 times, 5 minutes each time.
     
    Antibody incubation
    1. Use primary antibody dilution buffer to prepare the primary antibody working liquid (recommended dilution ratio for primary antibody 1:1000), gently shake and incubate with the film at 4°C overnight;
    2. Wash the film with TBST 3 times, 5 minutes each time;
    3. Add the secondary antibody to the blocking solution and incubate with the film gently at room temperature for 1 hour;
    4. After incubation, wash the film with TBST 3 times for 5 minutes each time.
     
    Antibody staining
    1. Add the prepared ECL luminescent substrate (or select other color developing substrate according to the second antibody) and mix evenly;
    2. Incubate with the film for 1 minute, remove excess substrate (keep the film moist), wrap with plastic film, and expose in the imaging system.

    Datasheet & SDS

    生物学的記述

    Specificity
    Cleaved IL-1β (Asp117) Antibody (Rabbit mAb) [F15J4] detects endogenous levels of total IL-1β protein only when cleaved at Asp117.
    タンパク質の局在
    細胞質、リソソーム、細胞外環境
    Uniprot ID
    P01584
    Clone
    F15J4
    Synonym(s)
    IL- | IL-1 beta | Il-1b | IL-1beta | Il1b | interleukin 1 beta | Interleukin-1 beta | OTTMUSP00000016525
    Background
    Cleaved IL‑1β (Asp117) refers to the mature, bioactive form of interleukin‑1β generated from the cytosolic precursor pro‑IL‑1β by site‑specific proteolysis at the caspase‑1 recognition motif between Asp116 and Ala117, a step that converts an inactive leaderless cytokine into a secreted mediator of innate immune signaling. Pro‑IL‑1β is induced by “priming” signals such as Toll‑like receptor ligands that activate NF‑κB and drive IL1B transcription, and the zymogen remains confined to the cytosol until inflammasome activation brings pro‑caspase‑1 into proximity with adaptor proteins like ASC and NLR family receptors, leading to caspase‑1 autoproteolysis, assembly of the active heterodimeric enzyme, and cleavage of pro‑IL‑1β at Asp116–Ala117 to generate the C‑terminal fragment that exposes a mature receptor‑binding surface. The Asp117‑terminated species engages the IL‑1 receptor type I in conjunction with the accessory protein IL‑1RAcP, initiating recruitment of MyD88, IRAK kinases, and TRAF6 and propagating signals through NF‑κB and MAPK cascades that drive transcription of additional inflammatory mediators, adhesion molecules, and chemokines, thereby amplifying leukocyte recruitment and effector functions. Maturation at Asp117 also licenses unconventional secretion, as caspase‑1 activity not only processes IL‑1β but also cleaves gasdermin D to form membrane pores that support rapid release during pyroptosis, while biochemical dissection of IL‑1β trafficking shows that the cleaved cytokine accumulates at PIP2‑rich plasma membrane ruffles via a polybasic motif and can exit more slowly through caspase‑1–independent, gasdermin D–independent routes once the maturation step has occurred. The processed Asp117 form is therefore a direct biochemical readout of canonical inflammasome pathway engagement and is widely used as a surrogate marker of caspase‑1 activation in macrophages, monocytes, and other myeloid cells exposed to microbial products, sterile danger signals, or metabolic stress. At a tissue level, accumulation of mature IL‑1β contributes to chronic inflammatory settings such as cancer, where tumor‑associated immune and stromal cells produce and release the cleaved cytokine after sequential priming and inflammasome activation; IL‑1β then shapes the tumor microenvironment by promoting angiogenesis, matrix remodeling, and myeloid cell recruitment, linking the presence of Asp117‑terminal IL‑1β to protumor inflammatory circuits. Genetic or pharmacologic disruption of inflammasome components, caspase‑1, or IL‑1β signaling reduces the generation or action of the Asp117 species and alters disease phenotypes in models of infection, fibrosis, and tumor growth.
    References

    技術サポート

    ストックの作り方、阻害剤の保管方法、細胞実験や動物実験の際に注意すべき点など、製品を取扱う時に問い合わせが多かった質問に対しては取扱説明書でお答えしています。

    Handling Instructions

    他に質問がある場合は、お気軽にお問い合わせください。

    * 必須

    大学・企業名を記入してください
    名前を記入してください
    電子メール・アドレスを記入してください 有効なメールアドレスを入力してください
    お問い合わせ内容をご入力ください